GOLDMAN SACHS PRIVATE EQUITY

C Value C Growth D Momentum C VGM Abbott's stock is trading at a huge premium, and it isn't a justifiable one for investors. Average price target from 25 ratings: $123.27 ABOUT ABBOTT Abbott detected bacteria eight times as its net profits soared by 94% between 2019 and 2021. And just as its tainted formula allegedly began sickening a number of bab